Elsevier launches ClinicalKey AI to redefine how clinical information is obtained

Elsevier Health announced a strategic partnership with OpenEvidence, a company specializing in medical artificial intelligence, to jointly develop the next generation of clinical decision support toolsClinicalKey AI , combining recent and trustworthy evidence-based medical content with generative artificial intelligence (AI) to assist doctors in clinical decision-making.

Even for experienced clinicians, regularly reading and processing huge amounts of data and information can be burdensome. By combining Elsevier's vast and trusted medical information with advanced artificial intelligence technology, ClinicalKey AI can help doctors obtain accurate evidence-based medical information when making clinical decisions.

“We believe ClinicalKey AI will be a game-changer in how doctors access information. By combining our best-in-class medical content with the powerful AI capabilities that OpenEvidence is known for, we can help doctors achieve tremendous results in the way they find and use information. Leap Ahead. This solution is tailor-made for time-pressed physicians who need precise answers to a variety of clinical questions backed by scientific research and responsible AI principles."

——Jan Herzhoff

President of Elsevier Medical Division

“ClinicalKey AI is exactly the solution doctors need. The product provides a natural language interface with carefully organized content and continuously updated evidence-based research that is critical for medical education and immediate decision-making. It’s clear , Elsevier Health listened to physicians and understood the challenges they face with the explosion of data and concerns about the ethical use of artificial intelligence in clinical practice. ClinicalKey AI is a significant advancement based on the solutions currently available, and I look forward to the Products will be widely used next year.”

What needs to be rewritten is:——Scott D. Solomon

He is a professor of medicine at Harvard Medical School and Brigham and Women's Hospital and editor of Braunwald Cardiology

We are honored to partner with Elsevier Health, a global leader. Elsevier Health has a strong heritage in health information and analytics and shares our commitment to improving health care outcomes around the world. By working closely together, we will play a greater role in addressing the critical challenges doctors face every day. OpenEvidence's artificial intelligence will help doctors obtain reliable medical content at the most critical moments. This is Elsevier's trustworthy

——Daniel Nadler

Founder of OpenEvidence

Elsevier Health's flagship product ClinicalKey is a leading clinical decision support and reference tool used by thousands of hospital systems and medical schools worldwide to support point-of-care care and in-depth reference. New feature ClinicalKey AI provides an advanced conversational search interface to help physicians find accurate, concise clinical information based on one of the largest and most trusted sources of medical information in the world today.

ClinicalKey AI’s main advantages include:

Conversational search can accelerate the acquisition of evidence-based clinical information: Through natural language question and answer, doctors can quickly obtain answers to questions related to treatment, conditions, and medications. Based on the latest research and expert opinion, the content is constantly updated and quality assured. Enhanced solutions are designed to help support physicians in increasing efficiency and productivity.

Solve complex medical problems with evidence-based information: Physicians can solve challenging cases by combining the latest research, reference books, clinical reviews, drug information and more that clinicians trust. Reference information and links are presented to the physician. Finally, ClinicalKey AI will support continuous questioning and recommend related possible questions for doctors’ reference. All content is licensed so users and institutions can trust the information being used.

Responsible AI Principles: ClinicalKey AI adheres to industry data privacy and security standards and Elsevier’s Responsible AI Principles.

For more than two decades, Elsevier has been combining artificial intelligence and machine learning technologies with its best-in-class peer-reviewed content and extensive data sets to create products that help make scientific research, life sciences and healthcare more efficient. By incorporating generative AI into its products, Elsevier aims to make it easier and more intuitive for customers to find information they can trust to accelerate scientific discovery, enhance collaboration and improve patient care.

ClinicalKey AI will be available in early access in November 2023, with full launch in the U.S. in early 2024. Institutional decision-makers of hospitals and medical schools (management, library staff, professors, directors, etc.) can apply for trial use of ClinicalKey AI. After the trial quota is opened, we will contact those who meet the conditions personnel for further contact.

The above is the detailed content of Elsevier launches ClinicalKey AI to redefine how clinical information is obtained. For more information, please follow other related articles on the PHP Chinese website!